Sanaluz Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SANALUZ
SANALUZ has five approved drugs.
Summary for Sanaluz
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Sanaluz
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanaluz | AMPHETAMINE SULFATE | amphetamine sulfate | TABLET;ORAL | 212582-001 | Feb 4, 2020 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanaluz | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 207127-001 | Feb 28, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanaluz | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 211690-002 | Feb 7, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sanaluz | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 207574-001 | Dec 13, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
